ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Vimela Therapeutics Limited

Vimela Therapeutics Limited is an active company incorporated on 9 September 2021 with the registered office located in . Vimela Therapeutics Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13611487
Private limited company
Age
4 years
Incorporated 9 September 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 8 September 2025 (2 months ago)
Next confirmation dated 8 September 2026
Due by 22 September 2026 (10 months remaining)
Last change occurred 1 year 2 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
The Cambridge Partnership The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge
CB22 3FH
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • French • Lives in Switzerland • Born in Nov 1970
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Methuselah Health UK Limited
The Cambridge Partnership Limited is a mutual person.
Active
Pandeia Therapeutics Limited
The Cambridge Partnership Limited is a mutual person.
Active
Elements Squared Limited
The Cambridge Partnership Limited is a mutual person.
Active
Ampkine Limited
The Cambridge Partnership Limited is a mutual person.
Active
S Xpress Bio Limited
The Cambridge Partnership Limited is a mutual person.
Active
Imhotex Limited
The Cambridge Partnership Limited is a mutual person.
Active
SDS Therapeutics Limited
The Cambridge Partnership Limited is a mutual person.
Active
Perfect Balance Bio Limited
The Cambridge Partnership Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£3.38M
Decreased by £2.49M (-42%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£3.43M
Decreased by £2.47M (-42%)
Total Liabilities
-£262.53K
Decreased by £101.05K (-28%)
Net Assets
£3.17M
Decreased by £2.37M (-43%)
Debt Ratio (%)
8%
Increased by 1.49% (+24%)
Latest Activity
Confirmation Submitted
2 Months Ago on 8 Sep 2025
Small Accounts Submitted
5 Months Ago on 11 Jun 2025
Small Accounts Submitted
1 Year 1 Month Ago on 9 Oct 2024
Confirmation Submitted
1 Year 2 Months Ago on 9 Sep 2024
Notification of PSC Statement
2 Years Ago on 6 Nov 2023
Francesco De Rubertis Resigned
2 Years Ago on 18 Oct 2023
Michele Ollier Bauer Resigned
2 Years Ago on 18 Oct 2023
Medicxi Iii Lp (PSC) Resigned
2 Years Ago on 18 Oct 2023
Andrea Epperly Resigned
2 Years Ago on 18 Oct 2023
Dr Thibaud Portal Appointed
2 Years Ago on 18 Oct 2023
Get Credit Report
Discover Vimela Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 8 September 2025 with no updates
Submitted on 8 Sep 2025
Accounts for a small company made up to 31 December 2024
Submitted on 11 Jun 2025
Accounts for a small company made up to 31 December 2023
Submitted on 9 Oct 2024
Confirmation statement made on 8 September 2024 with updates
Submitted on 9 Sep 2024
Change of share class name or designation
Submitted on 6 Nov 2023
Resolutions
Submitted on 6 Nov 2023
Memorandum and Articles of Association
Submitted on 6 Nov 2023
Change of share class name or designation
Submitted on 6 Nov 2023
Notification of a person with significant control statement
Submitted on 6 Nov 2023
Current accounting period extended from 30 September 2023 to 31 December 2023
Submitted on 27 Oct 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year